COGNITIVE AND QUANTIFIED ELECTROENCEPHALOGRAPHIC CORRELATES OF CYCLOSERINE TREATMENT IN ALZHEIMERS-DISEASE

被引:21
作者
MOHR, E
KNOTT, V
SAMPSON, M
WESNES, K
HERTING, R
MENDIS, T
机构
[1] UNIV OTTAWA, ROYAL OTTAWA HOSP, MENTAL HLTH RES INST, OTTAWA, ON, CANADA
[2] COGNIT DRUG RES LTD, READING, BERKS, ENGLAND
[3] SEARLE RES & DEV, SKOKIE, IL USA
关键词
CYCLOSERINE; ALZHEIMERS DISEASE; ELECTROENCEPHALOGRAPHY;
D O I
10.1097/00002826-199502000-00004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cycloserine acts as a potent and selective modulator of the N-methyl-D-aspartate (NMDA) receptor-associated glycine recognition site, which may be a possible mechanism for this compound's positive effects on memory formation and retrieval processes in animals. Studies in normal human volunteers have shown that cycloserine can have significant positive effects on cognitive processing in the elderly and can ameliorate memory deficits induced by subcutaneously administered scopolamine. Based on this profile, a double-blind, placebo controlled, parallel group (three drug dosages) study was conducted as part of a larger study to assess the efficacy and safety, as well as the cognitive and central nervous system (CNS) impact, of 6 months of cycloserine treatment in patients (N = 40) with probable dementia of the Alzheimer type (DAT). The Cognitive Drug Research Computerized Assessment System (CDR System) served as the primary outcome measure of efficacy. CNS activity was assessed using quantified electroencephalography (QEEG). Safety measures included adverse effects documentation and analysis of blood chemistry/hematology. Cycloserine proved to be a safe agent in this population at the doses given but failed to show any statistically significant effects in the areas of cognition and global clinical ratings and did not indicate significant CNS activity on QEEG. These findings suggest that cycloserine has no measurable therapeutic effect on Alzheimer's disease at the doses given.
引用
收藏
页码:28 / 38
页数:11
相关论文
共 41 条
[1]   LONG-TERM POTENTIATION AND NMDA RECEPTORS IN RAT VISUAL-CORTEX [J].
ARTOLA, A ;
SINGER, W .
NATURE, 1987, 330 (6149) :649-652
[2]   THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[3]   A LONGITUDINAL EEG STUDY OF MILD SENILE DEMENTIA OF ALZHEIMER TYPE - CHANGES AT 1 YEAR AND AT 2.5 YEARS [J].
COBEN, LA ;
DANZIGER, W ;
STORANDT, M .
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1985, 61 (02) :101-112
[4]   REPLICATION OF A STUDY OF FREQUENCY-ANALYSIS OF THE RESTING AWAKE EEG IN MILD PROBABLE ALZHEIMERS-DISEASE [J].
COBEN, LA ;
CHI, D ;
SNYDER, AZ ;
STORANDT, M .
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1990, 75 (03) :148-154
[5]   NMDA RECEPTORS - THEIR ROLE IN LONG-TERM POTENTIATION [J].
COLLINGRIDGE, GL ;
BLISS, TVP .
TRENDS IN NEUROSCIENCES, 1987, 10 (07) :288-293
[6]   EXCITATORY AMINO-ACID NEUROTRANSMISSION - NMDA RECEPTORS AND HEBB-TYPE SYNAPTIC PLASTICITY [J].
COTMAN, CW ;
MONAGHAN, DT ;
GANONG, AH .
ANNUAL REVIEW OF NEUROSCIENCE, 1988, 11 :61-80
[7]  
DAVIDOFF RA, 1984, HDB SPINAL CORD, V2, P166
[8]   BRAIN ELECTRICAL-ACTIVITY IN PATIENTS WITH PRESENILE AND SENILE DEMENTIA OF THE ALZHEIMER TYPE [J].
DUFFY, FH ;
ALBERT, MS ;
MCANULTY, G .
ANNALS OF NEUROLOGY, 1984, 16 (04) :439-448
[9]  
EMMETT MR, 1990, SC49088 D CYCLOSERIN
[10]   AN OBJECTIVE CLASSIFICATION OF PSYCHOACTIVE-DRUGS [J].
FINK, M .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY, 1980, 4 (4-5) :495-502